Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
Shiheng Jia , Xue Yu , Na Deng , Chen Zheng , Mingguang Ju , Fanglin Wang , Yixiao Zhang , Ziming Gao , Yanshu Li , Heng Zhou , Kai Li
Clinical and Translational Medicine ›› 2025, Vol. 15 ›› Issue (1) : e70190
Deciphering the pseudouridine nucleobase modification in human diseases: From molecular mechanisms to clinical perspectives
•Methods to detect pseudouridine were introduced from classic mass spectrometry-based methods to newer approaches such as nanopore-based technologies and BID sequencing, each with its advantages and limitations. | |
•RNA pseudouridylation is crucial for various biological processes, including tRNA homeostasis, tRNA transport, translation initiation regulation, pre-mRNA splicing, enhancement of mRNA translation, and translational fidelity. | |
•Increased pseudouridylation is frequently associated with tumour initiation, progression, and poor prognosis, whereas its reduction is predominantly implicated in non-tumour diseases. | |
•A comprehensive understanding of the inducing factors for RNA pseudouridylation will be essential for elucidating its role in diseases. Such insights can provide robust evidence for how pseudouridylation influences disease progression and offer new avenues for therapeutic strategies targeting pseudouridylation dysregulation. | |
•The therapeutic potential of RNA pseudouridylation in diseases is enormous, including inhibitors targeting pseudouridine synthases, the application of RNA pseudouridylation in RNA therapeutics, and its role as a biological marker. |
cancer / disease / post-transcriptional modification / pseudouridylation
2025 The Author(s). Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.
/
| 〈 |
|
〉 |
PDF
